Synthesis of ( p‐ tolyl)‐3(2 H )pyridazinone Derivatives as Novel Acetylcholinesterase Inhibitors

[1]  Anonymous,et al.  2022 Alzheimer's disease facts and figures , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  Mehtap Uysal,et al.  3(2H)-Pyridazinone Derivatives: Synthesis, In-Silico Studies, Structure-Activity Relationship and In-Vitro Evaluation for Acetylcholinesterase Enzyme İnhibition , 2022, Journal of Molecular Structure.

[3]  Li Zhang,et al.  Design, synthesis, and cholinesterase inhibition assay of liquiritigenin derivatives as anti-Alzheimer's activity. , 2021, Bioorganic & medicinal chemistry letters.

[4]  Naga Rajiv Lakkaniga,et al.  Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease. , 2021, Bioorganic & medicinal chemistry.

[5]  Razi Ahmad,et al.  Alzheimer's disease and its treatment by different approaches: A review. , 2021, European journal of medicinal chemistry.

[6]  Bashir A Akhoon,et al.  Discovery of a New Donepezil-like Acetylcholinesterase Inhibitor for Targeting Alzheimer's Disease: Computational Studies with Biological Validation , 2020, J. Chem. Inf. Model..

[7]  B. Tang,et al.  Association of rare variants in neurodegenerative genes with familial Alzheimer’s disease , 2020, Annals of clinical and translational neurology.

[8]  S. Rivest,et al.  Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer’s disease , 2020, Journal of Neuroinflammation.

[9]  D. Teplow,et al.  Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease. , 2019, Brain : a journal of neurology.

[10]  Suat Sarı,et al.  A new series of pyndazinone derivatives as chohnesterases inhibitors: Synthesis, in vitro activity and molecular modeling studies , 2019, Pharmacological reports : PR.

[11]  M. Kumar,et al.  Cu-mediated synthesis of differentially substituted diazepines as AChE inhibitors; validation through molecular docking and Lipinski's filter to develop novel anti-neurodegenerative drugs. , 2019, Bioorganic & medicinal chemistry letters.

[12]  I. Orhan,et al.  A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies. , 2019, Mini reviews in medicinal chemistry.

[13]  Murat Senturk,et al.  Effects of aryl methanesulfonate derivatives on acetylcholinesterase and butyrylcholinesterase , 2018, Journal of biochemical and molecular toxicology.

[14]  Hayriye Yılmaz,et al.  Design, synthesis, and molecular modeling of new 3(2H)-pyridazinone derivatives as acetylcholinesterase/butyrylcholinesterase inhibitors , 2017, Medicinal Chemistry Research.

[15]  T. Rosenberry,et al.  Structures of human acetylcholinesterase bound to dihydrotanshinone I and territrem B show peripheral site flexibility. , 2013, ACS medicinal chemistry letters.

[16]  Dong Lu,et al.  Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors. , 2013, European journal of medicinal chemistry.

[17]  Noel Southall,et al.  Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. , 2010, Bioorganic & medicinal chemistry letters.

[18]  R. Damoiseaux,et al.  Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors. , 2009, Bioorganic & medicinal chemistry.

[19]  A. Karaburun,et al.  Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities. , 2004, European journal of medicinal chemistry.